Flortaucipir (18F)
http://dbpedia.org/resource/Flortaucipir_(18F) an entity of type: Thing
Флортауципир (18F) — радиофармацевтический препарат для диагностики болезни Альцгеймера. Одобрен для применения: США (2020).
rdf:langString
Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain. The most common adverse reactions include headache, injection site pain and increased blood pressure. It is the first drug used to help image a distinctive characteristic of Alzheimer's disease in the brain called tau pathology. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
rdf:langString
rdf:langString
Flortaucipir (18F)
rdf:langString
Flortaucipir (18F)
rdf:langString
Flortaucipir (18F)
xsd:integer
64105317
xsd:integer
1117137976
rdf:langString
flortaucipir F 18
rdf:langString
None
xsd:integer
1522051
xsd:integer
3545253
xsd:integer
32701063
rdf:langString
Flortaucipir
rdf:langString
DB14914
xsd:integer
7
rdf:langString
D11210
rdf:langString
Rx-only
xsd:double
262.27
xsd:integer
70957463
rdf:langString
C1=CC2=CNC4=C2C=NC=C4
xsd:integer
1
rdf:langString
GETAAWDSFUCLBS-SJPDSGJFSA-N
xsd:integer
18
rdf:langString
Tauvid
rdf:langString
T1JP1KYU9O
rdf:langString
Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain. The most common adverse reactions include headache, injection site pain and increased blood pressure. Two proteins – tau and amyloid – are recognized as hallmarks of Alzheimer's disease. In people with Alzheimer's disease, pathological forms of tau proteins develop inside neurons in the brain, creating neurofibrillary tangles. After flortaucipir (18F) is administered intravenously, it binds to sites in the brain associated with this tau protein misfolding. The brain can then be imaged with a PET scan to help identify the presence of tau pathology. It is the first drug used to help image a distinctive characteristic of Alzheimer's disease in the brain called tau pathology. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
rdf:langString
Флортауципир (18F) — радиофармацевтический препарат для диагностики болезни Альцгеймера. Одобрен для применения: США (2020).
rdf:langString
C16H10[18F]N3
rdf:langString
Flortaucipir
rdf:langString
Tauvid
rdf:langString
flor tau' si pir 18 F
xsd:string
C16H10[18F]N3
xsd:nonNegativeInteger
12427
rdf:langString
Tauvid
xsd:string
1522051-90-6
xsd:string
3545253
xsd:string
DB14914
xsd:string
T1JP1KYU9O
xsd:string
D11210
xsd:string
70957463